Simed Global Introduces Rapid Diagnostic Innovation Outpacing VAR’s Offside Verifications

Last Updated on:

Simed Global, a distinguished entity within the UK’s healthcare industry, is spearheading the development of a novel diagnostic approach that enables quick testing for Tuberculosis, RSV, and the identification of viral versus bacterial infections through saliva analysis.

Their state-of-the-art instant diagnostic CX device, capable of conducting patient screenings within an astonishing 60 seconds, represents a monumental advancement in diagnostic technology.

This pioneering innovation not only diminishes waiting times but also ensures the swift isolation and treatment of patients, effectively halting the spread of infectious diseases and contributing to the preservation of lives.

Mirroring the vexation felt by football fans towards the prolonged reviews by VAR, healthcare professionals have lamented over the extensive duration required to obtain test outcomes.

In response, Simed Global commits to providing patients with accurate results, cognisant of the detrimental effects that erroneous or delayed information can have on therapeutic decisions. Their saliva-based diagnostic tests, with an impressive 98% precision rate, assure patients of immediate and reliable results.

Healthcare experts in search of an efficient triage solution have found their answer in Simed Global’s innovative offering, achieving a significant milestone in medical diagnostics.

For additional information, reach out to: diagnostics@simedglobal.com or access www.simedglobal.com